Search Results

Strategies for Screening and Characterizing Targeted Covalent Inhibitors

Strategies for Screening and Characterizing Targeted Covalent Inhibitors

Emerging strategies in covalent inhibition

Emerging strategies in covalent inhibition

Kinetic characterisation of covalent inhibitors on the PHERAstar

Kinetic characterisation of covalent inhibitors on the PHERAstar

Fragment-Based Drug Discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances

Fragment-Based Drug Discovery — Hitting Targets Using the Right Chemistry and Expertise Alliances

Targeted covalent inhibitors with an emphasis on reversible covalent inhibition

Targeted covalent inhibitors with an emphasis on reversible covalent inhibition

Webinar - Development of Covalent Drugs with New Emerging Technologies

Webinar - Development of Covalent Drugs with New Emerging Technologies

Drug Lead Discovery: Fragment Screening and Characterization Using Multiplexed SPR

Drug Lead Discovery: Fragment Screening and Characterization Using Multiplexed SPR

Dan Nomura - Dana-Farber Targeted Degradation Webinar Series

Dan Nomura - Dana-Farber Targeted Degradation Webinar Series

Sara Buhrlage - Dana-Farber Targeted Degradation Webinar Series

Sara Buhrlage - Dana-Farber Targeted Degradation Webinar Series

Successful Hit Finding for PIM3 Kinase Inhibitors: From HTS to Extended Hit Characterization

Successful Hit Finding for PIM3 Kinase Inhibitors: From HTS to Extended Hit Characterization

Introduction into Fragment Based Drug Discovery

Introduction into Fragment Based Drug Discovery

Hit Generation - Webinar (Part Four: Classical Screening Strategies - Screening Technologies)

Hit Generation - Webinar (Part Four: Classical Screening Strategies - Screening Technologies)